Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Impairment and restrictions in possibly benign multiple sclerosis.

Schaefer LM, Poettgen J, Fischer A, Gold S, Stellmann JP, Heesen C.

Brain Behav. 2019 Mar 18:e01259. doi: 10.1002/brb3.1259. [Epub ahead of print]

2.

Benefit evaluation in multiple sclerosis relapse treatment from the patients' perspective - Development and validation of a new questionnaire.

Beckmann H, Augustin M, Heesen C, Poettgen J, Blome C.

Mult Scler Relat Disord. 2019 Feb;28:256-261. doi: 10.1016/j.msard.2018.12.021. Epub 2018 Dec 17.

PMID:
30639826
3.

Short-term interval aerobic exercise training does not improve memory functioning in relapsing-remitting multiple sclerosis-a randomized controlled trial.

Baquet L, Hasselmann H, Patra S, Stellmann JP, Vettorazzi E, Engel AK, Rosenkranz SC, Poettgen J, Gold SM, Schulz KH, Heesen C.

PeerJ. 2018 Dec 12;6:e6037. doi: 10.7717/peerj.6037. eCollection 2018.

4.

Risk knowledge of people with relapsing-remitting multiple sclerosis - Results of an international survey.

Giordano A, Liethmann K, Köpke S, Poettgen J, Rahn AC, Drulovic J, Beckmann Y, Sastre-Garriga J, Galea I, Heerings M, Jongen PJ, Vettorazzi E, Solari A, Heesen C; AutoMS group.

PLoS One. 2018 Nov 29;13(11):e0208004. doi: 10.1371/journal.pone.0208004. eCollection 2018.

5.

Perceptions on the value of bodily functions in multiple sclerosis.

Heesen C, Haase R, Melzig S, Poettgen J, Berghoff M, Paul F, Zettl U, Marziniak M, Angstwurm K, Kern R, Ziemssen T, Stellmann JP.

Acta Neurol Scand. 2018 Mar;137(3):356-362. doi: 10.1111/ane.12881. Epub 2017 Dec 3.

PMID:
29205262
6.

Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires.

Fischer A, Fischer M, Nicholls RA, Lau S, Poettgen J, Patas K, Heesen C, Gold SM.

Brain Behav. 2015 Sep;5(9):e00365. doi: 10.1002/brb3.365. Epub 2015 Jul 14.

7.

Risk Knowledge in Relapsing Multiple Sclerosis (RIKNO 1.0)--Development of an Outcome Instrument for Educational Interventions.

Heesen C, Kasper J, Fischer K, Köpke S, Rahn A, Backhus I, Poettgen J, Vahter L, Drulovic J, Van Nunen A, Beckmann Y, Liethmann K, Giordano A, Fulcher G, Solari A; AutoMS-group.

PLoS One. 2015 Oct 2;10(10):e0138364. doi: 10.1371/journal.pone.0138364. eCollection 2015.

8.

Magnetic resonance imaging in multiple sclerosis--patients' experiences, information interests and responses to an education programme.

Brand J, Köpke S, Kasper J, Rahn A, Backhus I, Poettgen J, Stellmann JP, Siemonsen S, Heesen C.

PLoS One. 2014 Nov 21;9(11):e113252. doi: 10.1371/journal.pone.0113252. eCollection 2014.

9.

A 3meter Timed Tandem Walk is an early marker of motor and cerebellar impairment in fully ambulatory MS patients.

Stellmann JP, Vettorazzi E, Poettgen J, Heesen C.

J Neurol Sci. 2014 Nov 15;346(1-2):99-106. doi: 10.1016/j.jns.2014.08.001. Epub 2014 Aug 10.

PMID:
25156343
10.

Behavioral interventions in multiple sclerosis: a biopsychosocial perspective.

Heesen C, Köpke S, Kasper J, Poettgen J, Tallner A, Mohr DC, Gold SM.

Expert Rev Neurother. 2012 Sep;12(9):1089-100. doi: 10.1586/ern.12.103. Review.

PMID:
23039388
11.

HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis.

Möller F, Poettgen J, Broemel F, Neuhaus A, Daumer M, Heesen C.

Mult Scler. 2011 Aug;17(8):1002-9. doi: 10.1177/1352458511402410. Epub 2011 May 11.

PMID:
21561959
12.

Correlates of cognitive dysfunction in multiple sclerosis.

Heesen C, Schulz KH, Fiehler J, Von der Mark U, Otte C, Jung R, Poettgen J, Krieger T, Gold SM.

Brain Behav Immun. 2010 Oct;24(7):1148-55. doi: 10.1016/j.bbi.2010.05.006. Epub 2010 May 31.

PMID:
20621641

Supplemental Content

Loading ...
Support Center